199 related articles for article (PubMed ID: 38757345)
1. Targeting ferroptosis in hepatocellular carcinoma.
Mo Y; Zou Z; Chen E
Hepatol Int; 2024 Feb; 18(1):32-49. PubMed ID: 37880567
[TBL] [Abstract][Full Text] [Related]
2. The engineered exosomes targeting ferroptosis: A novel approach to reverse immune checkpoint inhibitors resistance.
Chen A; Zhang W; Jiang C; Jiang Z; Tang D
Int J Cancer; 2024 Jul; 155(1):7-18. PubMed ID: 38533694
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis/disulifidptosis-related gene SLC7A11 predicts prognosis, immune infiltration, and immunotherapy response in hepatocellular carcinoma.
Pan Y; Zhang Y; Zhu G; Li S
Asian J Surg; 2024 Jun; 47(6):2726-2728. PubMed ID: 38531741
[No Abstract] [Full Text] [Related]
4. Mitochondria-Derived Vesicles, Sterile Inflammation, and Pyroptosis in Liver Cancer: Partners in Crime or Innocent Bystanders?
Guerra F; Ponziani FR; Cardone F; Bucci C; Marzetti E; Picca A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732000
[TBL] [Abstract][Full Text] [Related]
5. The new era of lung cancer therapy: Combining immunotherapy with ferroptosis.
Li Y; Tuerxun H; Zhao Y; Liu X; Li X; Wen S; Zhao Y
Crit Rev Oncol Hematol; 2024 Jun; 198():104359. PubMed ID: 38615871
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis in antitumor therapy: Unraveling regulatory mechanisms and immunogenic potential.
Zhang T; Zeng X; Zeng E; Wang H
Int Immunopharmacol; 2024 Jun; 134():112203. PubMed ID: 38705030
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the Molecular Nexus: An In-Depth Review of Mitochondrial Pathways and Their Role in Cell Death Crosstalk.
Li Y; Rasheed M; Liu J; Chen Z; Deng Y
Cells; 2024 May; 13(10):. PubMed ID: 38786088
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity.
Meier P; Legrand AJ; Adam D; Silke J
Nat Rev Cancer; 2024 May; 24(5):299-315. PubMed ID: 38454135
[TBL] [Abstract][Full Text] [Related]
9. The role of regulated necrosis in diabetes and its complications.
Pang H; Huang G; Xie Z; Zhou Z
J Mol Med (Berl); 2024 Apr; 102(4):495-505. PubMed ID: 38393662
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in potential therapeutic targets of ferroptosis‑associated pathways for the treatment of stroke (Review).
Dong H; Ma YP; Cui MM; Qiu ZH; He MT; Zhang BG
Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38785160
[TBL] [Abstract][Full Text] [Related]
11. Lethal and sublethal effects of programmed cell death pathways on hematopoietic stem cells.
Yamada Y; Zheng Z; Jad AK; Yamashita M
Exp Hematol; 2024 Jun; 134():104214. PubMed ID: 38582294
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review).
Liu RJ; Yu XD; Yan SS; Guo ZW; Zao XB; Zhang YS
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757345
[TBL] [Abstract][Full Text] [Related]
13. PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy.
Zheng Y; Wang Y; Lu Z; Wan J; Jiang L; Song D; Wei C; Gao C; Shi G; Zhou J; Fan J; Ke A; Zhou L; Cai J
Adv Sci (Weinh); 2023 Oct; 10(29):e2301928. PubMed ID: 37705495
[TBL] [Abstract][Full Text] [Related]
14. The diversified role of mitochondria in ferroptosis in cancer.
Liu Y; Lu S; Wu LL; Yang L; Yang L; Wang J
Cell Death Dis; 2023 Aug; 14(8):519. PubMed ID: 37580393
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of targeting regulated non-apoptotic cell death.
Hadian K; Stockwell BR
Nat Rev Drug Discov; 2023 Sep; 22(9):723-742. PubMed ID: 37550363
[TBL] [Abstract][Full Text] [Related]
16. HIF-1α drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1.
Yang Z; Su W; Wei X; Qu S; Zhao D; Zhou J; Wang Y; Guan Q; Qin C; Xiang J; Zen K; Yao B
Cell Rep; 2023 Aug; 42(8):112945. PubMed ID: 37542723
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation.
Wang Y; Wang Y; Pan J; Gan L; Xue J
Radiother Oncol; 2023 Jul; 184():109689. PubMed ID: 37150447
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis-Enhanced Immunotherapy with an Injectable Dextran-Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma.
Meng J; Yang X; Huang J; Tuo Z; Hu Y; Liao Z; Tian Y; Deng S; Deng Y; Zhou Z; Lovell JF; Jin H; Liu Y; Yang K
Adv Sci (Weinh); 2023 Jul; 10(20):e2300517. PubMed ID: 37132587
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
